ID
16913
Description
Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen; ODM derived from: https://clinicaltrials.gov/show/NCT00191269
Link
https://clinicaltrials.gov/show/NCT00191269
Keywords
Versions (1)
- 8/14/16 8/14/16 -
Uploaded on
August 14, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Metastatic Breast Cancer NCT00191269
Eligibility Metastatic Breast Cancer NCT00191269
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Interstitial pneumonia or pulmonary fibrosis
Data type
boolean
Alias
- UMLS CUI [1]
- C0206061
- UMLS CUI [2]
- C0034069
Description
Inflammatory breast carcinoma
Data type
boolean
Alias
- UMLS CUI [1]
- C0278601
Description
latest chemotherapy, radiotherapy, hormonal/immunotherapy or surgery
Data type
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C0279025
- UMLS CUI [3]
- C1522449
- UMLS CUI [4]
- C0021083
- UMLS CUI [5]
- C0543467
Description
Brain metastasis
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
Severe complication
Data type
boolean
Alias
- UMLS CUI [1]
- C0027051
- UMLS CUI [2]
- C0009450
- UMLS CUI [3]
- C0013182
- UMLS CUI [4]
- C0011849
Similar models
Eligibility Metastatic Breast Cancer NCT00191269
- StudyEvent: Eligibility
C0796419 (UMLS CUI [2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0034069 (UMLS CUI [2])
C0279025 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0021083 (UMLS CUI [4])
C0543467 (UMLS CUI [5])
C0009450 (UMLS CUI [2])
C0013182 (UMLS CUI [3])
C0011849 (UMLS CUI [4])